Eric David Peterson, MD

Professor of Medicine
Fred Cobb, M.D. Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 200 Morris Street, Durham, NC 27701
Phone (919) 668-8830
Email address peter016@mc.duke.edu

Dr Peterson is the Fred Cobb Distinguished Professor of Medicine in the Division of Cardiology, a DukeMed Scholar, and the Past Executive Director of the Duke Clinical Research Institute (DCRI), Durham, NC, USA.

Dr Peterson is the Principal Investigator of the National Institute of Health, Lung and Blood Institute (NHLBI) Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT) Trial  He is also the Principal Investigator of the Data Coordinating Centers for the Society of Thoracic Surgeons (STS), National Cardiac Surgery Database, the American College of Cardiology National Cardiac Database (ACC-NCDR) and the American Heart Association Get With the Guidelines Database (AHA-GWTG).  Dr Peterson also oversees multiple industry sponsored clinical studies.

Additionally, Dr Peterson serves on multiple national committees and guideline and performance measure development groups. Dr Peterson is a member of the American Society for Clinical Investigation (ASCI), the Association of American Physicians (AAP), and the Association of University Cardiologists (AUC).

Since 2013, Dr Peterson has been voted one of world’s top 400 most influential researchers in biomedicine. as well as named by Thomson Reuters as a ‘Highly Cited Researcher’, ranking him among the top 1% most cited in clinical medicine. He is a Contributing Editor on the Journal of the American Medical Association and is a recognized leader in outcomes and quality research with over 1200 peer-reviewed publications in the field.

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1992 - 1995
  • Fellow in General Internal Medicine, Medicine, Harvard University , 1991 - 1992
  • Medical Resident, Medicine, Children's Hospital, Boston, 1988 - 1991
  • M.D., University of Pittsburgh, 1988

Publications

Gao, Yumin, Eric Peterson, and Neha Pagidipati. “Opportunities for improving use of evidence-based therapy in patients with type 2 diabetes and cardiovascular disease..” Clin Cardiol, August 26, 2019. https://doi.org/10.1002/clc.23252.

PMID
31448852
Full Text

Guimarães, Patrícia O., Eric D. Peterson, Susanna R. Stevens, Yuliya Lokhnygina, Jennifer B. Green, Darren K. McGuire, Rury R. Holman, and Renato D. Lopes. “Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes..” Int J Cardiol 289 (August 15, 2019): 58–62. https://doi.org/10.1016/j.ijcard.2019.04.085.

PMID
31079973
Full Text

Nanna, Michael G., Ann Marie Navar, Daniel Wojdyla, and Eric D. Peterson. “The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts..” J Am Geriatr Soc, August 14, 2019. https://doi.org/10.1111/jgs.16123.

PMID
31411740
Full Text

Rozjabek, Heather M., Craig I. Coleman, Veronica Ashton, François Laliberté, Paul Oyefesobi, Dominique Lejeune, Guillaume Germain, et al. “Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants..” J Med Econ 22, no. 8 (August 2019): 751–59. https://doi.org/10.1080/13696998.2019.1603156.

PMID
30939954
Full Text

Nanna, Michael G., Ann Marie Navar, Tracy Y. Wang, Shuang Li, Salim S. Virani, Zhuokai Li, Jennifer G. Robinson, et al. “Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry..” Am Heart J 214 (August 2019): 113–24. https://doi.org/10.1016/j.ahj.2019.05.009.

PMID
31202098
Full Text

Ali-Ahmed, Fatima, Jerome J. Federspiel, Li Liang, Haolin Xu, Theresa Sevilis, Adrian F. Hernandez, Andrzej S. Kosinski, et al. “Intravenous Tissue Plasminogen Activator in Stroke Mimics..” Circ Cardiovasc Qual Outcomes 12, no. 8 (August 2019). https://doi.org/10.1161/CIRCOUTCOMES.119.005609.

PMID
31412730
Full Text

Nanna, Michael G., Tracy Y. Wang, Qun Xiang, Anne C. Goldberg, Jennifer G. Robinson, Veronique L. Roger, Salim S. Virani, et al. “Sex Differences in the Use of Statins in Community Practice..” Circ Cardiovasc Qual Outcomes 12, no. 8 (August 2019). https://doi.org/10.1161/CIRCOUTCOMES.118.005562.

PMID
31416347
Full Text

Butt, Jawad H., Ang Li, Ying Xian, Eric D. Peterson, David Garcia, Christian Torp-Pedersen, Lars Køber, and Emil L. Fosbøl. “Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort..” Am Heart J 216 (July 25, 2019): 117–24. https://doi.org/10.1016/j.ahj.2019.07.012.

PMID
31425898
Full Text

Xian, Ying, Haolin Xu, Emily C. O’Brien, Shreyansh Shah, Laine Thomas, Michael J. Pencina, Gregg C. Fonarow, et al. “Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study..” Jama Neurol, July 22, 2019. https://doi.org/10.1001/jamaneurol.2019.2099.

PMID
31329212
Full Text

Jahan, Reza, Jeffrey L. Saver, Lee H. Schwamm, Gregg C. Fonarow, Li Liang, Roland A. Matsouaka, Ying Xian, et al. “Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice..” Jama 322, no. 3 (July 16, 2019): 252–63. https://doi.org/10.1001/jama.2019.8286.

PMID
31310296
Full Text

Pages